These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan. Landy SH, Tepper SJ, Wein T, Schweizer E, Ramos E. Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799 [Abstract] [Full Text] [Related]
4. Long-term efficacy of subcutaneous sumatriptan using a novel self-injector. Gross ML, Kay J, Turner AM, Jewsbury J, Cleal AL. Headache; 1995 Jan; 35(10):601-6. PubMed ID: 8550361 [Abstract] [Full Text] [Related]
5. Comparison of subcutaneous sumatriptan with usual acute treatments for migraine. French Sumatriptan Study Group. Boureau F, Chazot G, Emile J, Bertin L, d'Allens H. Eur Neurol; 1995 Jan; 35(5):264-9. PubMed ID: 8542914 [Abstract] [Full Text] [Related]
6. The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache. Cull RE, Price WH, Dunbar A. J Neurol Neurosurg Psychiatry; 1997 May; 62(5):490-5. PubMed ID: 9153607 [Abstract] [Full Text] [Related]
12. Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial. Cady RC, Ryan R, Jhingran P, O'Quinn S, Pait DG. Arch Intern Med; 1998 May 11; 158(9):1013-8. PubMed ID: 9588435 [Abstract] [Full Text] [Related]
13. A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice. Russell MB, Holm-Thomsen OE, Rishøj Nielsen M, Cleal A, Pilgrim AJ, Olesen J. Cephalalgia; 1994 Aug 11; 14(4):291-6. PubMed ID: 7954759 [Abstract] [Full Text] [Related]
14. Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: an 8-week open-label extension study. Landy S, Munjal S, Brand-Schieber E, Rapoport AM. J Headache Pain; 2018 Aug 15; 19(1):70. PubMed ID: 30112725 [Abstract] [Full Text] [Related]
15. Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial. Thomson AN, Arthur GP, Bergin PS, Pollock M, Parkin PJ, Flanagan M, Samson SA. N Z Med J; 1993 May 12; 106(955):171-3. PubMed ID: 8389026 [Abstract] [Full Text] [Related]
16. An open study of self-administration of subcutaneous sumatriptan to treat successive attacks of acute migraine. Portuguese Sumatriptan Auto-injector Study Group. J Int Med Res; 1994 May 12; 22(4):225-35. PubMed ID: 7958382 [Abstract] [Full Text] [Related]
17. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial. Schulman EA, Cady RK, Henry D, Batenhorst AS, Putnam DG, Watson CB, O'Quinn SO. Mayo Clin Proc; 2000 Aug 12; 75(8):782-9. PubMed ID: 10943230 [Abstract] [Full Text] [Related]
18. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study. Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M. Clin Ther; 2007 Jan 12; 29(1):99-109. PubMed ID: 17379050 [Abstract] [Full Text] [Related]
19. The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial. Diener HC, Tfelt-Hansen P, de Beukelaar F, Ferrari MD, Olesen J, Dahlöf C, Mathew N, Study Group. Cephalalgia; 2001 Jul 12; 21(6):672-9. PubMed ID: 11531899 [Abstract] [Full Text] [Related]
20. Managing migraine headaches experienced by patients who self-report with menstrually related migraine: a prospective, placebo-controlled study with oral sumatriptan. Dowson AJ, Massiou H, Aurora SK. J Headache Pain; 2005 Apr 12; 6(2):81-7. PubMed ID: 16362647 [Abstract] [Full Text] [Related] Page: [Next] [New Search]